Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2011
Cash flows from operating activities:      
Net income $ 543,149 $ 756,015 $ 794,488
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 87,534 92,133 86,044
Asset impairment charges 1,327 2,878 10,568
Net gain on sale of assets (1,160) 0 (1,372)
Non-cash stock-based compensation expense 70,084 78,835 81,430
Net gain on sale of marketable securities and other investments (2,287) (637) (2,479)
Deferred income taxes 4,532 193,412 64,736
Excess tax benefit from equity awards (14,198) 0 (71)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business combinations:      
Decrease (increase) in accounts receivable, net 159,245 (113,922) (128,219)
Decrease (increase) in inventories 14,787 (93,145) (170,141)
Decrease (increase) in other assets 6,035 58,041 (56,743)
Increase (decrease) in accounts payable (22,812) (3,732) 34,259
Increase (decrease) in deferred system profit 10,748 (45,121) (12,425)
Increase in other liabilities 56,204 16,860 123,091
Net cash provided by operating activities 913,188 941,617 823,166
Cash flows from investing activities:      
Capital expenditures, net (74,573) (57,596) (51,151)
Proceeds from sale of assets 1,838 2,228 18,185
Purchase of available-for-sale securities (1,588,093) (1,522,424) (1,142,491)
Proceeds from sale of available-for-sale securities 1,117,511 871,811 656,986
Proceeds from maturity of available-for-sale securities 300,209 174,854 138,776
Purchase of trading securities (40,850) (55,906) (63,005)
Proceeds from sale of trading securities 42,511 58,142 83,190
Net cash used in investing activities (241,447) (528,891) (359,510)
Cash flows from financing activities:      
Issuance of common stock 126,121 163,569 124,573
Tax withholding payments related to vested and released restricted stock units (29,682) (30,247) (22,557)
Common stock repurchases (273,254) (263,864) (234,844)
Payment of dividends to stockholders (265,893) (233,561) (167,398)
Excess tax benefit from equity awards 14,198 0 71
Net cash used in financing activities (428,510) (364,103) (300,155)
Effect of exchange rate changes on cash and cash equivalents (9,135) (8,658) 17,910
Net increase in cash and cash equivalents 234,096 39,965 181,411
Cash and cash equivalents at beginning of period 751,294 711,329 529,918
Cash and cash equivalents at end of period 985,390 751,294 711,329
Supplemental cash flow disclosures:      
Income taxes paid, net 120,342 20,018 262,086
Interest paid 53,693 54,523 52,819
Purchase of land, property and equipment $ 6,839 $ 0 $ 0